DOI: 10.32364/2587-6821-2024-8-9-3
A.V. Dreval1, O.A. Nechaeva1, O.A. Dreval2, T.A. Britvin2, A.R. Gabrielyan1
1N.A. Semashko National Research Institute of Public Health, Moscow, Russian Federation
2M.F. Vladimirskiy Moscow Regional Research and Clinical Institute, Moscow, Russian Federation
This review article initiates a series focused on metabolic medicine, a field that has yet to receive adequate attention within the domestic medical education system. The primary aim of this series is to demonstrate the prospects in understanding metabolic diseases and contemporary treatment modalities, with particular emphasis on those intersecting with endocrinology. The review defines metabolic medicine, explores its historical evolution, and outlines its principal trajectories. It also addresses the specialization within metabolic medicine, discussing the potential benefits this knowledge holds for various medical specialists. Furthermore, the article examines the treatment methodologies for prevalent and socially significant conditions, such as obesity and type 2 diabetes mellitus, through the lens of metabolic medicine. It underscores the pivotal role of metabolic specialists in patient management with metabolic syndrome, a common precursor to diabetes mellitus and cardiovascular diseases if not corrected in a timely manner. Emphasis is placed on reviewing bariatric surgical interventions, with a critical comparison of their efficacy and potential side effects. Additionally, the article highlights the critical role of metabolic medicine specialists in the management of patients who have undergone bariatric surgery.
Keywords: metabolic medicine, metabolologist, nutritionist, diabetes mellitus, obesity, metabolic syndrome, metabolism, nutritional support, parenteral nutrition.
For citation: Dreval A.V., Nechaeva O.A., Dreval O.A., Britvin T.A., Gabrielyan A.R. Metabolic medicine. Russian Medical Inquiry. 2024;8(9):518–525 (in Russ.). DOI: 10.32364/2587-6821-2024-8-9-3
About the authors:
Alexander V. Dreval — Dr. Sc. (Med.), Professor, Head of the Department of Endocrinology and Digital Medicine, N.A. Semashko National Research Institute of Public Health; 12, build. 1, Vorontsovo Pole, Moscow, 105064, Russian Federation; ORCID iD 0000-0002-3135-9003
Olga A. Nechaeva — C. Sc. (Med.), Associate Professor of the Department of Endocrinology and Digital Medicine, N.A. Semashko National Research Institute of Public Health; 12, build. 1, Vorontsovo Pole, Moscow, 105064, Russian Federation.
Oleg A. Dreval — C. Sc. (Med.), Researcher at the Department of Therapeutic Endocrinology of the Department of General Endocrinology. M.F. Vladimirskiy Moscow Regional Research and Clinical Institute; 61/2, Shchepkin str., Moscow, 129110, Russian Federation; ORCID iD 0000-0002-8944-9837
Timur A. Britvin — Dr. Sc. (Med.), Leading Researcher at the Department of Surgery, M.F. Vladimirskiy Moscow Regional Research and Clinical Institute; 61/2, Shchepkin str., Moscow, 129110, Russian Federation; ORCID iD 0000-0001-6160-1342
Artur R. Gabrielyan — Professor of the Department of Public Health and Healthcare, N.A. Semashko National Research Institute of Public Health; 12, build. 1, Vorontsovo Pole, Moscow, 105064, Russian Federation.
Contact information: Alexander V. Dreval, e-mail: endocrinolog-cab@yandex.ru
Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.
There is no conflict of interest.
Received 11.07.2024.
Revised 05.08.2024.
Accepted 28.08.2024.
References
1. Bistrian B.R., Blackburn G.L., Vitale J. et al. Prevalence of malnutrition in general medical patients. JAMA. 1979;235:1567–1570. DOI: 10.1001/jama.1976.03260410023017
2. Weinsier R.L., Hunker E.M., Krumdieck C.L., Butterworth C.E.Jr. Hospital malnutrition. A prospective evaluation of general medical patients during the course of hospitalization. Am J Clin Nutr. 1979;32:418–426. DOI: 10.1093/ajcn/32.2.418
3. Dudrick S.J., Wilmore D.W., Vars H.M., Rhoads J.E. Long-term total parenteral nutrition with growth, development and positive nitrogen balance. Surgery. 1968;64:134–142.
4. Dudrick S.J. History of parenteral nutrition. J Am Coll Nutr. 2009;28:243–251. DOI: 10.1080/07315724.2009.10719778
5. Dudrick S.J., Rhoads J.E. New horizons for intravenous feedings. JAMA. 1971;215:939–949. DOI: 10.1001/jama.1971.03180190057013
6. Dudrick S.J., Long J.M., Steiger E., Rhoads J.E. Intravenous hyperalimentation. Med Clin N Am. 1970;54:577–589. DOI: 10.1016/S0025-7125(16)32628-1
7. Dudrick S.J., Ruberg T.L. Principles and practice of parenteral nutrition. Gastroenterology. 1971;61:901–910. DOI: 10.1016/S0016-5085(19)33406-7
8. Skoutakis V.A., Martinez D.R., Miller W.A. Team approach to total parenteral nutrition. Am J Hosp Pharm. 1975;32:693–697. DOI: 10.1093/ajhp/32.7.693
9. Brown R.O., Minard G. Parenteral nutrition. In: Shils M.E., Shike M., eds. Modern Nutrition in Health and Disease. Lippincott Williams & Wilkins, Ambler, PA; 2006.
10. Schuberth O., Wretlind A. Intravenous infusion of fat emulsions, phosphatides and emulsifying agents. Acta Chir Scand. 1961;278(Suppl):1–21.
11. Vinnars E., Wilmore D. Jonathan Roads Symposium Papers. History of parenteral nutrition. JPEN J Parenter Enteral Nutr. 2003;27:225–231. DOI: 10.1177/0148607103027003225
12. Rothkopf M.M. Concept and scope of intensive homecare. In: Rothkopf M.M., Askanazi J., eds. Intensive Homecare. Lippincott Williams & Wilkins, Baltimore, MA; 1992.
13. Blackburn G.L., Greenberg I. Multidisciplinary approach to adult obesity therapy. Int J Obesity. 1978;2:133–142.
14. Bistrian B.R. Clinical use of a protein-sparing modified fast. JAMA. 1978;2401:2299–2302. DOI: 10.1001/jama.1978.03290210081040
15. Fujioka K. Follow-up of nutritional and metabolic problems after bariatric surgery. Diabetes Care. 2005;28:481–484. DOI: 10.2337/diacare.28.2.481
16. Reaven G.M. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607. DOI: 10.2337/diab.37.12.1595
17. Grundy S.M., Brewer H.B. Jr, Cleeman J.I. et al.; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–438. DOI: 10.1161/01.CIR.0000111245.75752.C6
18. Ridker P.M., Wilson P.W.F., Grundy S.M. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation. 2004;109:2818–2825. DOI: 10.1161/01.CIR.0000132467.45278.59
19. Marchesini G., Brizi M., Bianchi G. et al. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes. 2001;50:1844–1850. DOI: 10.2337/diabetes.50.8.1844
20. Ervin R.B. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report. 2009;(13):1–7. PMID: 19634296.
21. Chung E.H., Curran P.J., Sivasankaran S. et al. Prevalence of metabolic syndrome in patients < or=45 years of age with acute myocardial infarction having percutaneous coronary intervention. Am J Cardiol. 2007;100:1052–1055. DOI: 10.1016/j.amjcard.2007.05.028
22. Mason E.E., Ito C. Gastric bypass in obesity. Surg Clin North Am. 1967;47(6):1345–1351. DOI: 10.1016/S0039-6109(16)38384-0
23. Alden J.F. Gastric and jejunoileal bypass. A comparison in the treatment of morbid obesity. Arch Surg. 1977;112(7):799–806. DOI: 10.1001/archsurg.1977.01370070011001
24. Griffen W.O. Jr, Young V.L., Stevenson C.C. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity. Ann Surg. 1977;186(4):500–509. DOI: 10.1097/00000658-197710000-00012
25. Torres J.C. Why I prefer gastric bypass distal Roux-en-Y gastroileostomy. Obes Surg. 1991;1(2):189–194. DOI: 10.1381/096089291765561268
26. Fobi M.A., Lee H. The surgical technique of the Fobi-Pouch operation for obesity (the transected silastic vertical gastric bypass). Obes Surg. 1998;8(3):283–288. DOI: 10.1381/096089298765554485
27. Rutledge R., Walsh T.R. Continued excellent results with the mini-gastric bypass: six-year study in 2.410 patients. Obes Surg. 2005;15(9):1304–1308. DOI: 10.1381/096089205774512663.2
28. Robert M., Espalieu P., Pelascini E. et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019;30;393(10178):1299–1309. DOI: 10.1016/S0140-6736(19)30475-1
29. Hussain A., Van den Bossche M., Kerrigan D.D. et al. Retrospective cohort study of 925 OAGB procedures. The UK MGB/OAGB collaborative group. Int J Surg. 2019;69:13–18. DOI: 10.1016/j.ijsu.2019.07.003
30. Buchwald H. The evolution of metabolic/bariatric surgery. Obes Surg. 2014;24(8):1126–1135. DOI: 10.1007/s11695-014-1354-3
This work is licensed under a
Creative Commons «Attribution» 4.0 License.
Previous article
Next article
